# A Comparison Study Between Adolescents With Asthma and Adults With Asthma on How They Absorb, Metabolise and Eliminate CHF 6001

> **NCT06900816** · PHASE2 · COMPLETED · sponsor: **Chiesi Farmaceutici S.p.A.** · enrollment: 50 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** CHF 6001
- **DRUG:** CHF 6001

## Key facts

- **NCT ID:** NCT06900816
- **Lead sponsor:** Chiesi Farmaceutici S.p.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-03-28
- **Primary completion:** 2025-08-11
- **Final completion:** 2025-08-11
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2025-11-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06900816

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06900816, "A Comparison Study Between Adolescents With Asthma and Adults With Asthma on How They Absorb, Metabolise and Eliminate CHF 6001". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT06900816. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*